Connection
Robert McQueen to Indoles
This is a "connection" page, showing publications Robert McQueen has written about Indoles.
|
|
Connection Strength |
|
|
|
|
|
0.141 |
|
|
|
-
McQueen RB, Whittington MD, Chapman RH, Kumar VM, Campbell JD. Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States". Pharmacoeconomics. 2019 07; 37(7):963-964.
Score: 0.141